Kreftlex retweetledi
Arbeidslivet må være oppmerksom på at demens kan ramme midt i livet.Mer kunnskap kan gi flere en verdig avslutning. frifagbevegelse.no/loaktuelt/nar-…
Norsk
Kreftlex
227 posts
Kreftlex
@Kreftlex
https://t.co/ZiPZZyKiBE er et oppslagsverk tilpasset pasienter, pårørende og andre som søker kvalitetssikret kunnskap om kreft. Redaksjonen er en del av @Medinfonet
Oslo universitetssykehus, Oslo Katılım Şubat 2014
156 Takip Edilen216 Takipçiler
Kreftlex retweetledi
Do not forget to follow Sepp De Raedts presentation on AI in diagnostics! @nvidia @OsloCancer @OsloScienceCity @UniOslo_MED @unilabs @unioslo_mn @NORAdotAI @radforsk media-exp1.licdn.com/dms/image/C562…
English
Kreftlex retweetledi
Har du lyst til å hjelpe oss med å formidle forskning og pasientinformasjon? Vi søker en ny videoprodusent! #ledigstilling #ledigjobb finn.no/job/fulltime/a…
Norsk
Kollega Andreas Kleppe om hvorfor han som informatiker har valgt å jobbe med nettopp kreftforskning:
ICGI@MedinfoNet
Thanks to IFI at @unioslo_mn for the generous invitation to present Andreas Kleppe his AI approach and the efforts to improve cancer diagnostics. @Oslounivsykehus @forskningsradet bit.ly/39lOmdi
Norsk
Kreftlex retweetledi
Ny NORA podcast er ute! I denne episoden intervjuer Klas Pettersen og Morten Goodwin Håvard E. Danielsen, leder av Institutt for kreftgenetikk og informatikk ved Oslo Universitetssykehus HF, og prosjektleder for DoMore! nora.ai/podcast/
Norsk
Kreftlex retweetledi
Vi søker erfaren overingeniør til vårt arbeid med å forbedre diagnostikk og prognose for kreftpasienter. @UniOslo @OsloCancer @Oslounivsykehus @Inven2as #DoMore @Tidsskriftet @Bioingenioren @biovitenskap @radforsk
shorturl.at/cixJ1
Norsk
Kreftlex retweetledi
AI transformation of medical practices can go faster with better design of deep learning studies, according to a Perspective from our ICGI researchers lnkd.in/dt2Kqau nature.com/articles/s4156… #deeplearningalgorithms #Cancer #medicine #Domore
English
Kreftlex retweetledi
Perspective: Better study design will facilitate the development of deep learning systems that could transform current medical practice. Predefine the primary analysis and use more varied training data. What do you reckon, @EricTopol? nature.com/articles/s4156… @NatureRevCancer
English
Norsk
Kreftlex retweetledi
@mbrettha at @UniOslo_MED questioned @TheLancet whether it was taken sufficient account of lead-time bias in our deep learning system to predict colorectal patients survival. Here’s our answer thelancet.com/journals/lance… @Oslounivsykehus @forskningsradet @Inven2as.
English
Kreftlex retweetledi
The Institute for Cancer Genetics and Informatics is looking for an employee with knowledge of, and experience with, cytogenetic and molecular cytogenetic (FISH) methods used in genetic cancer diagnostics. #diagnostics finn.no/job/fulltime/a…
English
Kreftlex retweetledi
The Institute of Cancer Genetics and Informatics is looking for an employee with knowledge of, and experience with, cytogenetic and molecular methods used in cancer genetics. The tasks will be linked to research #diagnostics finn.no/job/fulltime/a…
English
Kreftlex retweetledi
A novel marker might contribute to selecting high-risk stage I ovarian carcinoma patients for adjuvant chemotherapy and low-risk endometrial carcinoma patients for less extensive surgery. #cancer #diagnostics #AI #machinelearing alphagalileo.org/en-gb/Item-Dis…
English
Kreftlex retweetledi
Diversity of chromatin compartments relates to chromatin heterogeneity and poor prognosis. #GynaecologicalCarcinomas @forskningsradet @OsloCancer @agz_eriksson mdpi.com/2072-6694/12/1…
English
Kreftlex retweetledi
FANTASTIC NEWS today that we will get a new Novaseq sequencing instrument in the ICR Genomics Core, Division of Cancer Medicine @Oslounivsykehus for research and diagnostics in InPreD to stratify patients to trials like IMPRESS funded by @radiumlegat and @Kreftforeningen
English
Kreftlex retweetledi
We are so grateful for the support from Radiumhospitalets Legater and the Norwegian Cancer Society - both being major contributors throughout many years supporting research, technology and competence building in Cancer Genomics 🙏🏻 @Kreftforeningen @radiumlegat
Kjetil Tasken@KjetilTasken
FANTASTIC NEWS today that we will get a new Novaseq sequencing instrument in the ICR Genomics Core, Division of Cancer Medicine @Oslounivsykehus for research and diagnostics in InPreD to stratify patients to trials like IMPRESS funded by @radiumlegat and @Kreftforeningen
English
Kreftlex retweetledi
Congratulation to Ph.D. fellow Ole-Johan Skrede and his co-writers for receiving one of OUS awards for best research articles in spring of 2020! oslo-universitetssykehus.no/om-oss/nyheter…
@OsloCancer
@Oslounivsykehus
@forskningsradet
@Kreftforeningen
@Kreftlex
English
Kreftlex retweetledi
Gratulerer så mye med midler fra @Kreftforeningen til prosjektleder @annetinestaff & postdoc @OxanaGavrilyuk 🙌🏼👊🏼🙌🏼
Blir spennende å følge prosjektet! Klikk linken for mer info 👇
kreftforeningen.no/aktuelt/open-c… @Oslounivsykehus @UniOslo #cancer #gynecology #pregnancy @KjetilTasken
Norsk
Gratulerer til alle våre dyktige kolleger i @MedinfoNet. Cudos for å utnytte kunstig intelligens til direkte nytte for pasienter og samfunn.
ICGI@MedinfoNet
Many thanks to the @Kreftforeningen for funds and trust in our project Polyp classification by artificial intelligence. @forskningsradet @OsloCancer @Inven2as #Domore! #Domorediagnostics #artificialintelligence #technologies #cancer kreftforeningen.no/aktuelt/open-c…
Norsk
Kreftlex retweetledi
Sjekk ut denne informative videoen fra @kjetilboye i forbindelse med Den Digitale Kuleuka - Hva er #sarkom? youtu.be/r5KzX2IasuI via @YouTube @Oslounivsykehus @ungkreft @kreftkompasset @Kreftlex @Kreftforeningen @OsloCancer @ParorendeAllian @Vardesenteret
YouTube
Norsk